Back to LCTX
VANGUARD GROUP INC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
20
Latest value
$12.6M
Q4 2025
Peak value
$537.7M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $398K |
| Q1 2025 | $537.7M |
| Q1 2025 | $1.3M |
| Q1 2025 | $2.4M |
| Q1 2025 | $478K |
| Q2 2025 | $828K |
| Q2 2025 | $391.7M |
| Q2 2025 | $1M |
| Q2 2025 | $2M |
| Q2 2025 | $385K |
| Q3 2025 | $924K |
| Q3 2025 | $2.5M |
| Q3 2025 | $2.5M |
| Q3 2025 | $332.9M |
| Q3 2025 | $13.1M |
| Q4 2025 | $2.2M |
| Q4 2025 | $299.1M |
| Q4 2025 | $802K |
| Q4 2025 | $2.2M |
| Q4 2025 | $12.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $12.6M | 359.2K | — | — |
| Q4 2025 | $2.2M | 64.0K | — | — |
| Q4 2025 | $802K | 22.9K | — | — |
| Q4 2025 | $299.1M | 8.55M | — | — |
| Q4 2025 | $2.2M | 63.9K | — | — |
| Q3 2025 | $13.1M | 340.0K | — | — |
| Q3 2025 | $332.9M | 8.62M | — | — |
| Q3 2025 | $2.5M | 64.3K | — | — |
| Q3 2025 | $2.5M | 63.9K | — | — |
| Q3 2025 | $924K | 23.9K | — | — |
| Q2 2025 | $385K | 8.8K | — | — |
| Q2 2025 | $2M | 46.1K | — | — |
| Q2 2025 | $1M | 23.9K | — | — |
| Q2 2025 | $391.7M | 9.00M | — | — |
| Q2 2025 | $828K | 19.0K | — | — |
| Q1 2025 | $478K | 8.2K | — | — |
| Q1 2025 | $2.4M | 41.4K | — | — |
| Q1 2025 | $1.3M | 22.5K | — | — |
| Q1 2025 | $537.7M | 9.17M | — | — |
| Q1 2025 | $398K | 6.8K | — | — |
Other funds holding LCTX
$259.1M
$242.5M
$238.9M
$219.8M
$204.8M
$201.2M
$200.2M
$151.1M